-
Does Keurig Green Mountain's Crash Make It A Value Play? Three Analysts Discuss
Thursday, August 6, 2015 - 10:43am | 598Read More...Shares of Keurig Green Mountain Inc (NASDAQ: GMCR) plunged nearly 30 percent Thursday morning following a difficult quarterly print and disappointing guidance. The question Keurig shareholders are now asking is if the crash in the stock offers a "value" play opportunity. Stifel:...
-
Goldman Sachs Analyzes Keurig Green Mountain's Bear Thesis, Offers Defense
Friday, July 24, 2015 - 2:23pm | 442Read More...In a report published Friday, Goldman Sachs analyst Judy Hong defended Keurig Green Mountain Inc (NASDAQ: GMCR), noting that after analyzing the bear thesis, "asymmetric upside risk" does exist, but shares at its current price offer a "compelling investment opportunity" for long-term investors....
-
The Market's 3 Best Keurig Green Mountain Analysts
Tuesday, May 5, 2015 - 3:55pm | 158Read More...The top three analysts for Keurig Green Mountain Inc (NASDAQ: GMCR) were listed by TipRanks recently. Each of the three had more than 4 stars, with John Staszak at Argus Research the most highly rated of the top three. Staszak rated Keurig Green Mountain a Buy and maintained a $164 price...
-
Goldman Sachs Sees Multi-Year Growth Story At Keurig Green Mountain Inc
Tuesday, October 7, 2014 - 11:50am | 211Read More...Judy Hong of Goldman Sachs initiated coverage of Keurig Green Mountain Inc (NASDAQ: GMCR) on Tuesday with a Buy rating and $166 price target. “We believe Keurig Green Mountain is at the cusp of pivoting to a multi-layered, product cycle-driven growth story from a disruptive innovation...
-
UPDATE: Goldman Sachs Upgrades Lorillard as "Top Tobacco Pick"
Monday, March 17, 2014 - 8:48am | 107Read More...On Monday, Goldman Sachs upgraded shares of Lorillard (NYSE: LO) from Neutral to Buy and maintained a $60 price target. Lorillard is analyst Judy Hong's “top tobacco pick.” The analyst believes the cigarette market is entering a “menthol regulation lull” and her price target implies “a sizeable...
-
Monster Beverage Continues to Plunge on FDA Probe
Tuesday, October 23, 2012 - 4:20pm | 168Read More...Monster Beverage (NASDAQ: MNST) plunged again on Tuesday after Goldman Sachs (NYSE: GS) removed the stock from its Conviction Buy list, while the firm kept its "Buy" rating on shares. The FDA confirmed this week that it is investigating reports of people dying after drinking the company's Monster...
-
Goldman Sachs: General Mills' Pension Expenses Holding Back Earnings (GIS)
Wednesday, June 30, 2010 - 10:25am | 146Read More...General Mills (NYSE: GIS) released 4QFY10 numbers, and came in a little above expectations. Its EPS of $0.41 matched consensus estimates. General Mills also provided guidance for FY2011 EPS of $2.46-$2.48, below consensus of $2.50, because of $100 million higher noncash pension expenses in 2011....
-
Philip Morris Added To Goldman's Conviction Buy List
Monday, December 14, 2009 - 4:37pm | 98Read More...Cigarette maker Philip Morris (NYSE: PM) was added to the Goldman Sachs (NYSE: GS) conviction buy list today with analyst Judy Hong saying the company is being "significantly underappreciated by the market." Hong expects the international maker of Marlboros and other popular brands to earn 81 cents...


